cyclic adp-ribose has been researched along with ropivacaine in 1 studies
| Studies (cyclic adp-ribose) | Trials (cyclic adp-ribose) | Recent Studies (post-2010) (cyclic adp-ribose) | Studies (ropivacaine) | Trials (ropivacaine) | Recent Studies (post-2010) (ropivacaine) |
|---|---|---|---|---|---|
| 758 | 0 | 144 | 3,869 | 1,982 | 1,857 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, QL; He, X; Peng, QY; Zou, Y | 1 |
1 other study(ies) available for cyclic adp-ribose and ropivacaine
| Article | Year |
|---|---|
Inhibition of CD38/Cyclic ADP-ribose Pathway Protects Rats against Ropivacaine-induced Convulsion.
Topics: ADP-ribosyl Cyclase 1; Amides; Animals; Calcium Signaling; Cyclic ADP-Ribose; Male; Malondialdehyde; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Sprague-Dawley; Ropivacaine; Seizures; Signal Transduction; Superoxide Dismutase | 2017 |